#MRVI Maravai LifeSciences Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/MRVI/maravai-life-s...

Charts of the Day - small-cap stocks forming piercing line candlestick signal, Thu Oct 30th - #HPP #MRVI - More: crystalequityresearch.com/charts-of-th... - #smallcap

Maravai LifeSciences Reports Second Quarter 2025 Financial Results Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercialized vaccine programs, grew 5% year-over-year Net Loss

#MRVI Maravai LifeSciences Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/MRVI/maravai-life-s...

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology TriLink BioTechnologies, a Maravai LifeSciences company (NASDAQ: MRVI), has entered into a non-exclusive License and Supply Agreement with Quantoom Biosciences for CleanCap mRNA capping technology. The agreement allows Quantoom to integrate TriLink's CleanCap technology into its Ntensify (sa)mRNA production platform. CleanCap technology achieves over 95% efficiency in producing 5′ cap structures and significantly improves mRNA yield and process time compared to traditional methods. The partnership aims to accelerate RNA production and increase accessibility of therapeutics and vaccines globally. CleanCap technology, launched in 2017, is currently used in most approved COVID-19 mRNA and saRNA vaccines. The collaboration focuses on enabling Quantoom's customers to develop (sa)mRNA drugs through clinical development phases using the integrated platform.

#MRVI TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

www.stocktitan.net/news/MRVI/tri-link-bio-t...

Major mRNA Vaccine Breakthrough: TriLink and IVI Join Forces to Transform Global Vaccine Access Strategic partnership combines TriLink's CleanCap technology with IVI's global reach to accelerate mRNA vaccine development for underserved markets. Learn more.

#MRVI TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines

www.stocktitan.net/news/MRVI/tri-link-bio-t...

Maravai Lifesciences Reports First Quarter 2025 Financial Results Maravai LifeSciences (NASDAQ: MRVI) reported challenging Q1 2025 financial results with revenue of $46.9 million, down 27.0% year-over-year. The company posted a net loss of $(52.9) million, including a $12.4 million goodwill impairment, and negative Adjusted EBITDA of $(10.5) million. The decline was primarily driven by the Nucleic Acid Production segment, which fell 37.5% to $28.8 million due to lack of high-volume CleanCap orders for commercial vaccine programs. Biologics Safety Testing revenue remained relatively flat at $18.1 million. Despite challenges, management maintained full-year 2025 revenue guidance of $185.0-205.0 million, citing solid execution in their base business which grew by $4 million compared to Q4 2024.

#MRVI Maravai Lifesciences Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/MRVI/maravai-lifesc...

Investors of Maravai LifeSciences Holdings, Inc. Face Class Action Lawsuit's Upcoming Deadline The Gross Law Firm warns shareholders of Maravai LifeSciences Holdings, Inc. of an ongoing class action lawsuit with critical deadlines. Learn more here.

Investors of Maravai LifeSciences Holdings, Inc. Face Class Action Lawsuit's Upcoming Deadline #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#TTWO, #BWA, #MRVI, #GETY, #LHX

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #TTWO 8.1x
2. #BWA 4.2x
3. #MRVI 4.1x
4. #XYZ 3.6x
5. #GETY 2.9x

#OptionFlow #OptionsTrading #Trading

Levi & Korsinsky Alerts Investors of Class Action for Maravai LifeSciences - Deadline Approaching Levi & Korsinsky LLP has informed shareholders of Maravai LifeSciences Holdings, Inc. about an upcoming class action lawsuit with a lead plaintiff deadline of May 5, 2025.

Levi & Korsinsky Alerts Investors of Class Action for Maravai LifeSciences - Deadline Approaching #USA #New_York #Class_Action #Maravai_LifeSciences #MRVI

Investors in Maravai LifeSciences Now Have Chance to Lead Securities Fraud Lawsuit Investors who faced losses with Maravai LifeSciences can now step forward to lead a class action suing for securities fraud following mismanagement allegations.

Investors in Maravai LifeSciences Now Have Chance to Lead Securities Fraud Lawsuit #United_States #Los_Angeles #Securities_Fraud #Maravai_LifeSciences #MRVI

Seize the Opportunity: Maravai LifeSciences Investors Can Lead Securities Fraud Lawsuit Investors who lost money in Maravai LifeSciences Holdings, Inc. (MRVI) now have a chance to partake in a significant securities fraud lawsuit.

Seize the Opportunity: Maravai LifeSciences Investors Can Lead Securities Fraud Lawsuit #USA #Los_Angeles #Frank_R._Cruz #Maravai_LifeSciences #MRVI

Investors Encouraged to Join Class Action Against Maravai LifeSciences Holdings for Financial Mismanagement The Gross Law Firm is calling on investors in Maravai LifeSciences Holdings to join a class action lawsuit concerning financial discrepancies during a recent class period.

Investors Encouraged to Join Class Action Against Maravai LifeSciences Holdings for Financial Mismanagement #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

Investors of Maravai LifeSciences Holdings, Inc. Urged to Act Before May 5 Deadline in Securities Fraud Lawsuit Investors in Maravai LifeSciences Holdings, Inc. who experienced losses are encouraged to reach out before the May 5, 2025 deadline to file their claims.

Investors of Maravai LifeSciences Holdings, Inc. Urged to Act Before May 5 Deadline in Securities Fraud Lawsuit #United_States #Bensalem #Howard_G._Smith #Maravai_LifeSciences #MRVI

Investors of Maravai LifeSciences Holdings, Inc. Urged to Register for Class Action Lawsuit Maravai LifeSciences investors are reminded to register for a potential class action lawsuit. Deadline for lead plaintiff appointment is May 5, 2025.

Investors of Maravai LifeSciences Holdings, Inc. Urged to Register for Class Action Lawsuit #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

Investors in Maravai LifeSciences Have New Opportunity in Securities Fraud Case Investors who faced financial losses with Maravai LifeSciences have a chance to take the lead in a securities fraud lawsuit. Details revealed potential reporting issues.

Investors in Maravai LifeSciences Have New Opportunity in Securities Fraud Case #USA #Los_Angeles #Securities_Fraud #Maravai_LifeSciences #MRVI

Maravai LifeSciences Investors Seek Justice Through Securities Fraud Lawsuit Investors in Maravai LifeSciences Holdings, Inc. (MRVI) have a chance to lead a class action lawsuit regarding alleged securities fraud. Learn more about the case.

Maravai LifeSciences Investors Seek Justice Through Securities Fraud Lawsuit #USA #Los_Angeles #Securities_Fraud #Maravai_LifeSciences #MRVI

Class Action Lawsuit Against Maravai LifeSciences: Investor Compensation Details A class action has been initiated against Maravai LifeSciences, targeting investor losses linked to alleged securities fraud. Learn more about your rights.

Class Action Lawsuit Against Maravai LifeSciences: Investor Compensation Details #United_States #New_York #Levi_&_Korsinsky #MRVI #Maravai

Important Class Action Lawsuit Alert for Maravai LifeSciences Investors - Immediate Action Required Investors in Maravai LifeSciences Holdings, Inc. are urged to take immediate action regarding a class action lawsuit. The deadline for participation is May 5, 2025.

Important Class Action Lawsuit Alert for Maravai LifeSciences Investors - Immediate Action Required #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

Maravai LifeSciences Faces Legal Action Over Securities Violations: Key Information for Investors Maravai LifeSciences Holdings, Inc. is currently facing a lawsuit for alleged violations of securities law. Shareholders are urged to take action before the deadline.

Maravai LifeSciences Faces Legal Action Over Securities Violations: Key Information for Investors #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

Investors Encouraged to Join Class Action Against Maravai LifeSciences Holdings for Potential Recovery Maravai LifeSciences investors who have suffered losses are invited to join a class action lawsuit initiated by Levi & Korsinsky, LLP. The lawsuit addresses alleged fraud.

Investors Encouraged to Join Class Action Against Maravai LifeSciences Holdings for Potential Recovery #USA #New_York #Class_Action #Maravai_LifeSciences #MRVI

Shareholders of MRVI Face Class Action Suit: Know Your Rights with DJS Law Group Investors in Maravai LifeSciences Holdings, Inc. are urged to join a class action lawsuit regarding security violations. Discover your rights with DJS Law Group.

Shareholders of MRVI Face Class Action Suit: Know Your Rights with DJS Law Group #USA #Eastchester #MRVI #Maravai #DJS_Law

Opportunity for MRVI Investors to Lead in Maravai Lifesciences Lawsuit Against Securities Fraud Claims Investors in Maravai Lifesciences have a chance to become lead plaintiffs in a class action lawsuit concerning securities fraud, with a key deadline approaching.

Opportunity for MRVI Investors to Lead in Maravai Lifesciences Lawsuit Against Securities Fraud Claims #United_States #New_York #Rosen_Law_Firm #Maravai_LifeSciences #MRVI

Opportunity for Maravai LifeSciences Investors to Lead Fraud Lawsuit After Losses Investors of Maravai LifeSciences who incurred losses may have the chance to be lead plaintiffs in a securities fraud class action lawsuit.

Opportunity for Maravai LifeSciences Investors to Lead Fraud Lawsuit After Losses #USA #Los_Angeles #Securities_Fraud #Maravai_LifeSciences #MRVI

Class Action Filed Against Maravai LifeSciences: Seeking Recovery for Investors from Misleading Statements Maravai LifeSciences Holdings faces a class action lawsuit claiming misleading statements that inaccurately represented their financial standing, hurting investors.

Class Action Filed Against Maravai LifeSciences: Seeking Recovery for Investors from Misleading Statements #United_States #New_York #Gross_Law_Firm #Maravai_LifeSciences #MRVI

Maravai Investors Face Crucial Deadline: Class Action Claims Hidden Financial Issues Legal action targets Maravai over alleged financial misstatements. 21.7% stock plunge follows control issues and delayed reports. Key deadline approaches.

#MRVI Urgent Action Required for Maravai LifeSciences Investors Before May 5 Deadline

www.stocktitan.net/news/MRVI/urgent-action-...

Maravai Faces Major Lawsuit After 21% Stock Crash: Deadline Approaches Investors affected by alleged financial misstatements between Aug 2024-Feb 2025 must act by May 5. Claims include control issues and revenue recognition concerns.

#MRVI Maravai LifeSciences Investors Must Take Action Before Key May 5 Court Deadline

www.stocktitan.net/news/MRVI/maravai-life-s...

BREAKING NEWS: ( NASDAQ: #MRVI ) Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript

Urgent Alert: Maravai Investors Face May 5 Deadline After 21% Stock Drop - Key Details Revealed Securities lawsuit alleges Maravai misled investors on financial controls and revenue reporting. Stock fell 21.7% after delayed earnings. Learn about joining the class action by May 5.

#MRVI Time-Sensitive: Maravai Lifesciences (MRVI) Investors May Have Legal Claims - Act Before May 5 Deadline

www.stocktitan.net/news/MRVI/time-sensitive...

Maravai Investors Face 21.7% Loss: Class Action Claims Financial Misreporting - May 5 Deadline Securities lawsuit alleges false statements on revenue recognition and controls. Investors who bought MRVI shares from Aug 2024-Feb 2025 have until May 5 to join as lead plaintiff.

#MRVI Maravai Lifesciences (MRVI) Investors Who Suffered Losses Encouraged to Contact Cohen Milstein

www.stocktitan.net/news/MRVI/maravai-lifesc...